Company Profile
Henry Schein Stock Price, News & Analysis
- Ticker:
- HSIC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
88.23 USD (-1.52%)
Close
Last updated: August 6, 2026
8.66B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, HSIC closed down 1.52% at $88.23. No new same-company headline was identified in the current news window.
Company overview
Business overview
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software. Its role is centered on healthcare distribution and practice support rather than biotech or medtech innovation.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Henry Schein has a global distribution footprint. It sits in healthcare distribution and dental supply rather than biotechnology.
Business Model Characteristics
The company generates revenue from product distribution, equipment sales, and software services for providers. Investors watch end-market demand, margin stability, and the health of dental and medical office spending.
Position Within the Biotechnology Landscape
Henry Schein is outside biotech, but it is part of the healthcare infrastructure that keeps clinical and dental practices operating. It moves on distribution volumes and practice demand, not drug catalysts.
Future catalysts
Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
Henry Schein to Present at Four Conferences in June
Source: Henry Schein
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Henry Schein (HSIC)?
Henry Schein (HSIC) most recently closed at 88.23 USD, a -1.52% move versus the previous session.
What is the market cap of Henry Schein (HSIC)?
Henry Schein currently has a market capitalization of 8.66B USD on BioPharmSignal.
What does Henry Schein do?
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software. Its role is centered on healthcare distribution and practice support rather than biotech or medtech innovation.
On which exchange is HSIC stock listed?
Henry Schein (HSIC) is associated with NASDAQ, United States, Biopharma.
What is Henry?
Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline.
Which conditions is Henry Schein targeting with Henry?
Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline.
How does Henry Schein describe recent progress with Henry?
Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline.
What is Schein?
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software.